Qurelac is a new concept probiotics that originates from Mediforum's biomedical technology; it's clinically proven potency for improving a weakened immune system, boosting intestinal gut flora and for effective weight-loss as well as strengthening the bones has been well established.

❶ Contains 12 specifically selected probiotic strains to improve the intestinal gut flora.

❷ Uses a patented formula of EC-12 Lactobacillus, processed and formulated on advanced heat-treated technology

❸ Incorporates prebiotics as nutrient sources for the probiotics

❹ Multifunctional effects, including strengthening immune system and fortifying intestinal gut flora, promoting healthy dieting and bone health, a stress reliever and an effective antioxidant.

❺ Provides relief specifically for dieting, constipation and immune disorders

These 12 probiotic strains are specifically chosen and mixed proportionally in our patented blend to provide the optimal impact to improving a weakened immune system, establishing a healthy intestinal gut flora, and providing regular bowel movements for healthy and effective dieting. Each of the 12 types of probiotics has a different and distinct role in the digestive system.

#1 Lactobacillus plantarum

#2 Lactobacillus rhamnosus

#3 Lactobacillus casei

#4 Lactobacillus salivarius

#5 Lactobacillus fermentum

#6 Lactobacillus acidophilus

#7 Lactococcus lactis

#8 Streptococcus thermophilus

#9 Bifidobacterium breve

#10 Bifidobacterium bifidum

#11 Bifidobacterium longum

#12 Bifidobacterium lactis

Japanese patented lactobacillus using an advanced heat treatment technique is utilize to create an incredibly high concentration of usable probiotics for your body. Our production technology allows us to pack 5 trillion lactobacillus colony forming units (CFU) per gram.

During a two week period, each participant was administered 200mg/EC-12/daily. During the intake period of EC-12, there was an increase in the proportion of Bifido Bacteria (beneficial bacteria) while there was a decrease in the level of Clostridium (harmful bacteria), observing the phenomenon of improved intestinal flora. In addition, more fecal matter was expelled, with higher moisture content, consistent with greater weight loss.

In the comparison between EC-12 and a placebo, those administered EC-12 after the two week trial showed a reduction in body fat composition, and in particular, a statistically substantial drop in visceral fat accumulations in the gut area. The change in Bacteroidetes (harmful bacteria) levels were also substantial, Bacteroidetes are a family of bacteria species that normally reside in the gut and most commonly associated with pathogenic outbreaks.

1. Confirmation of improvement on Atopic Dermatitis (400mg/daily/8 week period)
The administration of EC-12 showed a decrease in the formation of IgE antibodies (immunoglobulin E, which increases in the event that an allergen-inducing substance infiltrates the human body) which showed a degree of inhibition of atopic dermatitis.

2. Confirmation of improvement on Hay Fever (400mg/daily/8 week period)
The administration of EC-12 showed a decrease in the formation of IgE antibodies (immunoglobulin E, which increases in the event that an allergen-inducing substance infiltrates the human body) which showed a reduction in severity of hay fever.

3. Confirmation of anti-inflammatory effects on patients (400mg/daily/8 week period)
The administration of EC-12 showed a reduction in C-Reactive Protein (CRP) levels in the blood serum, reflecting a reduction in the inflammatory state of the body. Inflammatory cytokine levels in the blood serum also declined. Furthermore, Bifido Bacteria levels increased while frequency of defecation increased for prevention of constipation and increased quality of life.